glp 1 anxiety Transformation 2.0: The GLP-1 RAs as Psychiatric Medications? GLP-1 diabetes drugs could stop
Description
Acknowledgements This study was approved by the Alfred Hospital Ethics Committee (project number 463/18) and the Australian Institute of Health and Welfare Ethics Committee (EO2018/5/501)
Kramer CM, Borlaug BA, Zile MR, et al
A prospective case series study found that GLP-1RAs, such as liraglutide and exenatide, reduced the population of cutaneous T cells and the expression of IL-17 in skin lesions
They are not intended to replace prescription medications
The population was older white veterans and that may be a factor when considering pleotropic effects
